Category: Patent Policy
-
USPTO, DOJ file 3rd joint pro-injunction brief since June in standards-RELATED but NOT undisputedly standard-ESSENTIAL patent case: next stop Wilus v. Askey?
Patent holder Collision said that its patents-in-suit were not standard-essential and Samsung did not raise a FRAND defense, but Collision later made infringement arguments that were standards-related.
-

Nokia’s Vice President, IP Policy and Advocacy Head: “global policymakers recognize the importance of standards and that strong protection and enforcement of IPRs drives innovation”
“Open standards and FRAND licensing are the invisible infrastructure on which the digital economy is built,” Nokia’s Vice President and Head of IP Policy & Advocacy, Collette Rawnsley, told ip fray in an exclusive interview. “Without open standards and standard essential patents, there would be no smartphones, no connected devices, no video streaming.”
-
EU Commission study on application of IPR Enforcement Directive shows no pressing problem with patent assertion entities
The European Commission has released a report on the application of the EU’s IPR Enforcement Directive throughout the bloc. There does not appear to be a pressing need to legislate.
-

An interview with Manny Schecter, IBM’s former patent chief
“My biggest challenge was the constant need to educate inventors and business executives about IP and its importance for innovation,” Mr. Schecter, who served as IBM’s chief patent counsel for 14 years, told ip fray.
-
Make SEPs Great Again: after President’s memo on 6G, USPTO forms SEP Working Group “to renew American leadership in technology standards”
With President Trump’s 6G memo before and the USPTO’s SEP Working Group announcement after Christmas, standards and the related patents get unprecedented political attention.
-
Quantum-related patents increased fivefold in past decade, but high barriers to adoption: OECD-EPO report
While the number of international patent family applications has surged fivefold since 2014, 80% of companies in the sector do not have quantum as their main activity, and Europe faces notable challenges in commercializing its technology.
-
Teva removes more than 200 patents from U.S. FDA’s Orange Book: win for FTC
Following President Trump’s promise to lower the cost of drugs and a United States Federal Trade Commission investigation into a patent portfolio owned by Teva, the Israeli pharma company has asked the Food and Drug Administration to remove more than 200 improper patent listings related to asthma, diabetes, and COPD drugs, and epinephrine autoinjectors, from…
-
Encourage FRAND SEP licensing negotiations through patent pools, intermediaries: The World Bank recommends to low, middle-income nations
The World Bank’s first-ever report on standards has issued several recommendations to low and middle-income nations on how they can leverage standard-essential patents to propel their economies, pointing to China and the Republic of Korea as model examples.
-
UK consultation on SEP legislation closed two months ago, and they can already scrap their plans because of what has happened since
The UK government gave stakeholders 12 weeks to comment on its vision of global FRAND resolution, but the following month the landscape changed.
-
USPTO Director Squires encourages fairer, more consistent patent eligibility in latest memoranda
USPTO Director John A. Squires reminds applicants and examiners that when used properly, Subject-Matter Eligibility Declarations can be effective, encouraging examiners not to reject patent applications too broadly.
